MediWound (MDWD) Capital Leases (2019 - 2020)
MediWound (MDWD) recorded quarterly Capital Leases of $1.9 million in Q1 2020, down 5.03% quarter-over-quarter from $2.0 million in Q4 2019, and down 6.75% on a YoY basis from $2.0 million in Q2 2019.
MediWound (MDWD) Capital Leases (2019 - 2020) Analysis & Trends
MediWound's Capital Leases history runs 2 years deep, the most recent figure standing at $1.9 million for Q1 2020.
- In Q1 2020, Capital Leases fell 6.75% year-over-year to $1.9 million; the TTM figure through Mar 2020 stood at $1.9 million (down 6.75% YoY), while the FY2019 annual figure was $2.0 million, changed N/A from the prior year.
- Capital Leases was $1.9 million for Q1 2020 at MediWound, down from $2.0 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $2.0 million in Q1 2019 to a low of $1.9 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Jun 30, 2019 | 2.02 Mn |
| Mar 31, 2019 | 2.04 Mn |